ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
4,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
9,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
11,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
12,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
13,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
15,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
19,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
19,2,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
19,3,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
20,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
20,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
22,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
24,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
26,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,2,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
26,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
27,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
27,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
28,1,Application site coldness,Application site reactions,Administration site reactions,Genrl,N
28,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
29,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
29,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
30,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
30,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
30,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
31,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
31,2,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
32,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
32,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
32,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
33,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
33,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
33,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
34,2,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
34,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
34,4,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
35,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
35,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
35,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
35,4,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
35,5,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
35,6,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
35,7,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
36,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
37,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
38,1,Biopsy kidney abnormal,Urinary tract histopathology procedures,Renal and urinary tract investigations and urinalyses,Inv,N
38,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,3,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
41,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
42,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
43,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
43,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
43,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
44,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
44,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
44,4,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
44,5,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
44,6,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
45,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
46,2,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
46,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
46,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
46,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
46,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
48,1,Rhabdomyosarcoma,Rhabdomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
49,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,2,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
49,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
50,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
50,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
51,4,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
52,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
53,2,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
54,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
54,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
55,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
58,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
58,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
58,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
58,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
59,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
61,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
61,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
61,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
62,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Erythematotelangiectatic rosacea,Rosaceas,Skin appendage conditions,Skin,N
64,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
64,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
64,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
65,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
65,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
65,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
65,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
65,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
65,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
65,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
65,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
65,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
65,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
65,14,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
66,1,Acne,Acnes,Skin appendage conditions,Skin,N
66,2,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
66,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
66,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
66,6,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
68,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
68,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
69,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
69,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
69,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
69,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
69,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
69,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,7,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,8,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,9,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
69,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,11,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
69,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
71,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
72,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
72,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
72,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
72,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
72,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
72,7,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
73,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
73,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
73,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
73,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
73,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
74,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
75,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
76,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
76,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
76,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
76,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
76,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,7,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
77,1,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
77,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
78,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
79,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
80,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
80,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
80,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
80,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
80,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
80,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
80,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
82,1,Catheter management,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
83,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
83,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
84,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
85,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
85,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,3,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
86,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
87,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
87,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
88,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
89,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
89,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
90,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
90,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
90,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
91,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
91,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
91,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
93,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
94,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
95,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
96,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
96,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
96,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
97,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
